| RMEBX | TILVX | RMEBX / TILVX | |
| Total Expense Ratio | 1.07 | 0.05 | 2,140% |
| Annual Report Gross Expense Ratio | 1.07 | 0.05 | 2,140% |
| Fund Existence | 11 years | 23 years | - |
| Gain YTD | 14.940 | 14.029 | 106% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 112B | 11.8B | 949% |
| Annual Yield % from dividends | 1.05 | 1.79 | 59% |
| Returns for 1 year | 6.55 | 7.77 | 84% |
| Returns for 3 years | 30.03 | 32.12 | 93% |
| Returns for 5 years | 53.80 | 61.38 | 88% |
| Returns for 10 years | 92.20 | 95.30 | 97% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FMED | 27.32 | 0.20 | +0.74% |
| Fidelity Disruptive Medicine ETF | |||
| DFGX | 54.49 | -0.01 | -0.02% |
| Dimensional Global ex US Cor Fxd Inc ETF | |||
| MVLL | 25.37 | -0.05 | -0.20% |
| GraniteShares 2x Long MRVL Daily ETF | |||
| MMT | 4.72 | -0.02 | -0.42% |
| MFS Multimarket Income Trust | |||
| LFAI | 157.19 | -1.11 | -0.70% |
| LifeX 2050 Longevity Income ETF | |||